2013 Veterinary Research Fellowship

Kendra Freeman, DVM
Virginia Tech

Amanda-Jo Joswig, DVM, MPH
Texas A&M University


2013 Research Fellows

Left to Right: Wayne McIlwraith, BVSc, Ph.D., DSc, FRCVS, Diplomate ACVS & ACVSMR,
AAEP Foundation Chairman, Dr. Amanda-Jo Joswig, Dr. Ann Dwyer, AAEP President
and Dr. Richard Mitchell, EQUUS Foundation Board member.
Not pictured: Kendra Freeman, DVM, who was unable to attend because of a recent surgery.


Two equine researchers were presented with the 2013 EQUUS Foundation Research Fellows for their work to advance veterinary knowledge during the American Association of Equine Practitioners' 59th Annual Convention in Nashville, Tennessee. Virginia Tech equine surgery resident Kendra Freeman, DVM, and Texas A&M University post-doctoral research associate Amanda-Jo Joswig, DVM, MPH, each received a $5,000 grant from the EQUUS Foundation to support their endeavors in equine research along with a $500 stipend to support their travel to the AAEP Convention.
Kendra Freeman, DVM
Virginia Tech

Dr. Freeman's research evaluates the effect of tendon repair techniques on intrinsic tendon vasculature. The study compares the effects of the three-loop pulley pattern and the six-strand Savage suture patterns for tenorrhaphy on the perfusion intrinsic tendon vasculature of the equine superficial digital flexor tendon.

The project will provide valuable information to veterinarians who treat life-threatening tendon lacerations.

Dr. Freeman received her DVM from Colorado State University in 2009 and also is pursuing a Masters in Biomedical Veterinary Sciences.
Amanda-Jo Joswig, DVM, MPH
Texas A&M University

Dr. Joswig's research investigates the use of mesenchymal stem cells (MSCs) in equine corneal ulcers as well as the safety of allogeneic MSCs used subconjunctivally. The study dually aims to determine whether horses mount an immune reaction to allogeneic MSCs injected subconjunctivally and to characterize corneal epithelial healing times when MSCs are used as a therapeutic.

The project has the potential to change the current paradigm for treatment of equine corneal ulcers and provide a novel use of MSCs and a basis for translational applications in other species, including humans.

Dr. Joswig earned her DVM and Masters in Public Health from the University of Florida in 2011.